Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Reflex Sympathetic Dystrophy Syndrome Association (RSDSA) is a national 501(c)(3) non-profit organization dedicated to providing support, education, and hope to those affected by Complex Regional Pain Syndrome (CRPS), formerly known as Reflex Sympathetic Dystrophy (RSD). Founded in 1984, the association focuses on promoting public and professional awareness of the condition to facilitate early diagnosis and treatment. RSDSA actively funds and supports research aimed at discovering better treatments and a potential cure for CRPS. They provide a variety of resources, including support groups, educational conferences, and advocacy initiatives to improve the quality of life for patients and their families. The organization serves as a critical link between the patient community, medical professionals, and researchers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reflex Sympathetic Dystrophy Syndrome Association.